Drug Pipeline

GT307 injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-10 NCT07534813
A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307)…		 overall status: "Not Yet Recruiting" → "Withdrawn"
2026-06-10 NCT07534813
A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307)…		 Enrollment reduced: 16 -> 0 participants
Active Studies by Phase
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06397963 Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients… Solid Tumor, Adult Recruiting
NCT06453057 Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid… Adult Recruiting
NCT06819280 Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced… Adult Recruiting
Sponsors Running GT307 injection Trials
Grit Biotechnology (3)
Get alerts when GT307 injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free